Results From a Pivotal, Open-Label, Phase II Study of...

Journal of Clinical Oncology 2012 / 02 Vol. 30; Iss. 6

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

Coiffier, B., Pro, B., Prince, H. M., Foss, F., Sokol, L., Greenwood, M., Caballero, D., Borchmann, P., Morschhauser, F., Wilhelm, M., Pinter-Brown, L., Padmanabhan, S., Shustov, A., Nichols, J., Carr
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2011.37.4223
Date:
February, 2012
File:
PDF, 112 KB
english, 2012
Conversion to is in progress
Conversion to is failed